SNT - Sevion Therapeutics
This page shows which of the focused investors we track hold SNT and how their positions changed, so you can see how much conviction the group has in the stock.
In Q3 2015 it was held by 1 manager with an aggregate reported value of $12K, which is 0.00% of the combined portfolio.
As of Q3 2015, 1 tracked institutional manager held SNT (Sevion Therapeutics) with an aggregate reported value of $12K — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades SNT — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q3 2015
- Ticker
- SNT
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | David Katz - Matrix Asset Advisors | 0.00% | - | 20,000 | $12K |
Loading holder history for SNT…